Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.600
+0.120 (8.11%)
At close: Jan 8, 2026
Stenocare Market Cap
Stenocare has a market cap or net worth of 69.11 million as of January 8, 2026. Its market cap has increased by 109.65% in one year.
Market Cap
69.11M
Enterprise Value
67.02M
Revenue
5.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 69.11M, a decrease of -78.86%. That is a compound annual growth rate of -24.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 63.93M | - |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.62T |
| Genmab | 130.34B |
| Coloplast | 126.66B |
| ALK-Abelló | 49.94B |
| Demant | 47.67B |
| H. Lundbeck | 41.51B |
| Zealand Pharma | 30.41B |
| Ambu A/S | 24.02B |